Fort Pitt Capital Group Lowers stake in Halyard Health Inc (HYH)

Halyard Health Inc (HYH) : Fort Pitt Capital Group reduced its stake in Halyard Health Inc by 0.45% during the most recent quarter end. The investment management company now holds a total of 23,547 shares of Halyard Health Inc which is valued at $818,729 after selling 106 shares in Halyard Health Inc , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Halyard Health Inc makes up approximately 0.10% of Fort Pitt Capital Group’s portfolio.

Other Hedge Funds, Including , North Star Asset Management Inc reduced its stake in HYH by selling 133 shares or 0.47% in the most recent quarter. The Hedge Fund company now holds 28,429 shares of HYH which is valued at $983,359. Halyard Health Inc makes up approx 0.11% of North Star Asset Management Inc’s portfolio.Joel Isaacson reduced its stake in HYH by selling 87 shares or 23.26% in the most recent quarter. The Hedge Fund company now holds 287 shares of HYH which is valued at $9,629.Kanaly Trust Co boosted its stake in HYH in the latest quarter, The investment management firm added 10 additional shares and now holds a total of 80 shares of Halyard Health Inc which is valued at $2,684. Gateway Investment Advisers added HYH to its portfolio by purchasing 13,513 company shares during the most recent quarter which is valued at $466,469.

Halyard Health Inc opened for trading at $35.08 and hit $36.11 on the upside on Thursday, eventually ending the session at $35.73, with a gain of 2.76% or 0.96 points. The heightened volatility saw the trading volume jump to 8,63,341 shares. Company has a market cap of $1,668 M.

On the company’s financial health, Halyard Health Inc reported $0.45 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.36. The company had revenue of $400.00 million for the quarter, compared to analysts expectations of $382.39 million. The company’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 EPS.

Many Wall Street Analysts have commented on Halyard Health Inc. Company shares were Reiterated by Stifel on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 38 from a previous price target of $37 .Company shares were Reiterated by Stifel on Jun 14, 2016 to “Buy”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .

Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.

Leave a Reply

Halyard Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Halyard Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.